Tsepamo: DTG Exposure at Conception Associated With Smaller Increase in Incidence of Neural Tube Defects in Updated Analysis

July 21-24, 2019; Mexico City, Mexico
In updated birth outcomes surveillance analysis, NTD prevalence slightly higher with DTG vs non-DTG ART (0.3% vs 0.1%; estimated difference: 0.20% to 0.27%).
Format: Microsoft PowerPoint (.ppt)
File Size: 233 KB
Released: July 24, 2019

Acknowledgements

Provided by USF

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@usf.edu
https://health.usf.edu/cpd

Produced in collaboration with
IAS 2019 Media Partner Logo
Educational grant provided by:
Gilead Sciences
ViiV Healthcare

Related Content

Expert-authored CCO slides on the impact of HIV infection on COVID-19 risk and disease severity and the impact of COVID-19 on access to HIV care

W. David Hardy, MD
Program Director
Monica Gandhi, MD, MPH
Released: September 25, 2020

Short video log from Dr. Jonathan Appelbaum on managing ART and reducing polypharmacy in an older woman with HIV who presents with frailty and multiple other comorbidities

Jonathan Appelbaum, MD, FACP, AAHIVS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 24, 2020 Expired: September 23, 2021

Download free expert-authored slides reviewing a patient case and the relevant data on polypharmacy and drug-drug interactions in older patients with HIV

Jonathan Appelbaum, MD, FACP, AAHIVS Released: September 24, 2020

Downloadable slides from CCO expert, Dr. Alain H. Litwin, on integrating HCV and HIV prevention and care strategies into addiction care settings

Alain H. Litwin, MD Released: September 18, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue